UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies

Journal of hematology and oncology, 2023-07, Vol.16 (1), p.83-83, Article 83

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity

Frontiers in immunology, 2016-11, Vol.7, p.480-480

2016

Link zum Volltext

Verfügbarkeit prüfen

The coming of age of engineered multivalent antibodies

Drug discovery today, 2015-05, Vol.20 (5), p.588-594

2015

Link zum Volltext

Verfügbarkeit prüfen

Programming Controlled Adhesion of E. coli to Target Surfaces, Cells, and Tumors with Synthetic Adhesins

ACS synthetic biology, 2015-04, Vol.4 (4), p.463-473

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor Immunotherapy Using Gene‐Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds

Stem cells (Dayton, Ohio), 2009-03, Vol.27 (3), p.753-760

2009

Link zum Volltext

Verfügbarkeit prüfen

Understanding the Spatial Topology of Artificial Immunological Synapses Assembled in T Cell-Redirecting Strategies: A Major Issue in Cancer Immunotherapy

Frontiers in cell and developmental biology, 2020-01, Vol.7, p.370-370

2020

Link zum Volltext

Verfügbarkeit prüfen

TGF‐β‐induced IGFBP‐3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion

Molecular oncology, 2020-10, Vol.14 (10), p.2609-2628

2020

Link zum Volltext

Verfügbarkeit prüfen

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential

Frontiers in oncology, 2021-02, Vol.10, p.593848-593848

2021

Link zum Volltext

Verfügbarkeit prüfen

Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

Oncoimmunology, 2022-12, Vol.11 (1), p.2034355-2034355

2022

Link zum Volltext

Verfügbarkeit prüfen

Perforin gene variant A91V in young patients with severe COVID-19

Haematologica (Roma), 2020-12, Vol.105 (12), p.2844

2020

Link zum Volltext

Verfügbarkeit prüfen

Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies

Oncoimmunology, 2022-12, Vol.11 (1), p.2054106-2054106

2022

Link zum Volltext

Verfügbarkeit prüfen

Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy

Pharmaceutics, 2022-12, Vol.15 (1), p.132

2022

Link zum Volltext

Verfügbarkeit prüfen

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses

Oncoimmunology, 2024, Vol.13 (1), p.2338558-2338558

2024

Link zum Volltext

Verfügbarkeit prüfen

Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes

The Journal of biological chemistry, 2014-01, Vol.289 (4), p.2457-2468

2014

Link zum Volltext

Verfügbarkeit prüfen

Role of nucleotide‐binding oligomerization domain 1 (NOD1) in pericyte‐mediated vascular inflammation

Journal of cellular and molecular medicine, 2016-05, Vol.20 (5), p.980-986

2016

Link zum Volltext

Verfügbarkeit prüfen

When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy

Theranostics, 2023-01, Vol.13 (3), p.1028-1041

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers

Journal for immunotherapy of cancer, 2022-12, Vol.10 (12), p.e005333

2022

Link zum Volltext

Verfügbarkeit prüfen

Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2

Advanced science, 2023-12, Vol.10 (34), p.e2304818-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Multivalent antibodies: when design surpasses evolution

Trends in biotechnology (Regular ed.), 2010-07, Vol.28 (7), p.355-362

2010

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte display: a novel antibody selection platform based on T cell activation

PloS one, 2009-09, Vol.4 (9), p.e7174-e7174

2009

Link zum Volltext

Verfügbarkeit prüfen

Applications of trimerbodies in cancer immunotherapy

International review of cell and molecular biology, 2022, Vol.369, p.71-87

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficient production of single-chain fragment variable-based N-terminal trimerbodies in Pichia pastoris

Microbial cell factories, 2014-08, Vol.13 (1), p.116-116, Article 116

2014

Link zum Volltext

Verfügbarkeit prüfen

Improved stability of multivalent antibodies containing the human collagen XV trimerization domain

mAbs, 2012-03, Vol.4 (2), p.226-232

2012

Link zum Volltext

Verfügbarkeit prüfen

Selection strategies for anticancer antibody discovery: searching off the beaten path

Trends in biotechnology (Regular ed.), 2015-05, Vol.33 (5), p.292-301

2015

Link zum Volltext

Verfügbarkeit prüfen

Induction of Human T Lymphocyte Cytotoxicity and Inhibition of Tumor Growth by Tumor-Specific Diabody-Based Molecules Secreted from Gene-Modified Bystander Cells

The Journal of immunology (1950), 2003-07, Vol.171 (2), p.1070-1077

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(84)
Humans
(69)
Animals
(44)
Immunology
(37)
Cancer
(32)
Mice
(31)
Oncology
(28)
Immunotherapy
(23)
Tumors
(23)
Medicine, Research & Experimental
(20)
Research & Experimental Medicine
(20)
Gene Therapy
(19)
Antigens
(18)
Proteins
(18)
Antibodies
(17)
Biotechnology & Applied Microbiology
(17)
Cancer Immunotherapy
(16)
T-Lymphocytes - Immunology
(16)
Biochemistry & Molecular Biology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies

Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity

The coming of age of engineered multivalent antibodies

Programming Controlled Adhesion of E. coli to Target Surfaces, Cells, and Tumors with Synthetic Adhesins

Tumor Immunotherapy Using Gene‐Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds

Understanding the Spatial Topology of Artificial Immunological Synapses Assembled in T Cell-Redirecting Strategies: A Major Issue in Cancer Immunotherapy

TGF‐β‐induced IGFBP‐3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential

Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

Perforin gene variant A91V in young patients with severe COVID-19

Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies

Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses

Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes

Role of nucleotide‐binding oligomerization domain 1 (NOD1) in pericyte‐mediated vascular inflammation

When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers

Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2

Multivalent antibodies: when design surpasses evolution

Lymphocyte display: a novel antibody selection platform based on T cell activation

Applications of trimerbodies in cancer immunotherapy

Efficient production of single-chain fragment variable-based N-terminal trimerbodies in Pichia pastoris

Improved stability of multivalent antibodies containing the human collagen XV trimerization domain

Selection strategies for anticancer antibody discovery: searching off the beaten path

Induction of Human T Lymphocyte Cytotoxicity and Inhibition of Tumor Growth by Tumor-Specific Diabody-Based Molecules Secreted from Gene-Modified Bystander Cells

Suchergebnisse filtern